Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects

Published 2010 View Full Article

Authors

Keywords

Journal

CLINICAL THERAPEUTICS

Volume 32, Issue 6, Pages 1188-1204

Publisher

Elsevier BV

Online

2010-07-16

DOI

10.1016/j.clinthera.2010.06.004

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

CLINICAL THERAPEUTICS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Create your own webinar